Literature DB >> 8595770

Osteogenic protein-1: biology and applications.

S D Cook1, D C Rueger.   

Abstract

Osteogenic proteins, also referred to as BMPs, are a family of bone matrix polypeptides isolated from a variety of mammalian species. These proteins are members of the transforming growth factor-beta superfamily of molecules that contain a highly conserved 7 cysteine transforming growth factor-beta domain in their C-termini. Use of recombinantly produced human osteogenic protein-1, also referred to as BMP-7, implanted in conjunction with bovine bone derived Type 1 collagen or various non-proteinaceous biodegradable carriers into surgically created large diaphyseal segmental defects in animals leads to the regeneration of new bone that is fully functional biologically and biomechanically. Further study has shown that osteogenic protein-1 can be used as a bone graft substitute to promote spinal fusion and to aid in the incorporation of metal implants. Finally, osteogenic protein-1 shows promise as an agent for repair of osteochondral defects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8595770

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Transfection of articular chondrocytes with rhBMP7 gene and its expression.

Authors:  Deyu Duan; Jingyuan Du; Yong Liu; Xiaodong Guo; Hong Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

2.  Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier.

Authors:  H Yuan; J D De Bruijn; X Zhang; C A Van Blitterswijk; K De Groot
Journal:  J Mater Sci Mater Med       Date:  2001-09       Impact factor: 3.896

3.  A novel ex vivo model for investigation of fluid displacements in bone after endoprosthesis implantation.

Authors:  C Gatzka; E Schneider; M L Knothe Tate; U Knothe; P Niederer; M L Knothe Tate
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

4.  Spinal fusion using an autologous growth factor gel and a porous resorbable ceramic.

Authors:  William R Walsh; Andreas Loefler; Sean Nicklin; Doug Arm; Ralph E Stanford; Yan Yu; Richard Harris; R M Gillies
Journal:  Eur Spine J       Date:  2004-03-18       Impact factor: 3.134

Review 5.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

6.  Extraction and characterization of native canine bone morphogenetic protein (cBMP) qualified with osteoinductivity.

Authors:  J Oksanen; A Marttinen; S Paatsama; T S Lindholm
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

7.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

8.  Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.

Authors:  Sarah N Flier; Harikrishna Tanjore; Efi G Kokkotou; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

9.  A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7.

Authors:  Z Dahabreh; G M Calori; N K Kanakaris; V S Nikolaou; P V Giannoudis
Journal:  Int Orthop       Date:  2008-12-04       Impact factor: 3.075

10.  Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.

Authors:  David J Hunter; Marilyn C Pike; Beth L Jonas; Eugene Kissin; Julie Krop; Tim McAlindon
Journal:  BMC Musculoskelet Disord       Date:  2010-10-10       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.